UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 155

Sortiert nach

The evolutionary history of lethal metastatic prostate cancer

Nature (London), 2015-04, Vol.520 (7547), p.353-357

2015

Volltextzugriff (PDF)

Hedgehog signalling in prostate regeneration, neoplasia and metastasis

Nature, 2004-10, Vol.431 (7009), p.707-712

2004

Volltextzugriff (PDF)

Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth

Molecular cancer therapeutics, 2010-02, Vol.9 (2), p.336-346

2010

Volltextzugriff (PDF)

Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression

Cancer research (Chicago, Ill.), 2011-03, Vol.71 (6), p.2108-2117

2011

Volltextzugriff (PDF)

Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements

Nature genetics, 2010-08, Vol.42 (8), p.668-675

2010

Volltextzugriff (PDF)

Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (1), p.16-22

2009

Volltextzugriff (PDF)

Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

Nature medicine, 2009-05, Vol.15 (5), p.559-565

2009

Volltextzugriff (PDF)

Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases

British journal of cancer, 2018-08, Vol.119 (3), p.347-356

2018

Volltextzugriff (PDF)

DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases

Science translational medicine, 2013-01, Vol.5 (169), p.169ra10

2013

Volltextzugriff (PDF)

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

eLife, 2014-10, Vol.3

2014

Volltextzugriff (PDF)

Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity

Cancer research (Chicago, Ill.), 2021-10, Vol.81 (19), p.4901-4909

2021

Volltextzugriff (PDF)

Proteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumors

Scientific reports, 2021-09, Vol.11 (1), p.18936-18936, Article 18936

2021

Volltextzugriff (PDF)

The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource

Cancer epidemiology, biomarkers & prevention, 2022-04, Vol.31 (4), p.715-727

2022

Volltextzugriff (PDF)

Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases

Endocrine-related cancer, 2023-08, Vol.30 (8), p.1

2023

Volltextzugriff (PDF)

Fanconi anemia pathway regulation by FANCI in prostate cancer

Frontiers in oncology, 2023-10, Vol.13, p.1260826-1260826

2023

Volltextzugriff (PDF)

DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity

Cancer research (Chicago, Ill.), 2008-11, Vol.68 (21), p.8954-8967

2008

Volltextzugriff (PDF)

Roles for the stem cell-associated intermediate filament nestin in prostate cancer migration and metastasis

Cancer research (Chicago, Ill.), 2007-10, Vol.67 (19), p.9199-9206

2007

Volltextzugriff (PDF)

Hypermethylation of CpG islands in primary and metastatic human prostate cancer

Cancer research (Chicago, Ill.), 2004-03, Vol.64 (6), p.1975-1986

2004

Volltextzugriff (PDF)

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer

PloS one, 2016-03, Vol.11 (3), p.e0150241-e0150241

2016

Volltextzugriff (PDF)

Detection and Verification of Glycosylation Patterns of Glycoproteins from Clinical Specimens Using Lectin Microarrays and Lectin-Based Immunosorbent Assays

Analytical chemistry (Washington), 2011-11, Vol.83 (22), p.8509-8516

2011

Volltextzugriff (PDF)

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine

Genome medicine, 2023-10, Vol.15 (1), p.82-82, Article 82

2023

Volltextzugriff (PDF)

Somatic Alterations Contributing to Metastasis of a Castration-Resistant Prostate Cancer

Human mutation, 2013-09, Vol.34 (9), p.1231-1241

2013

Volltextzugriff (PDF)

Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells

Cancer research (Chicago, Ill.), 2006-08, Vol.66 (15), p.7509-7515

2006

Volltextzugriff (PDF)

Cancer genomics: Human metastases under scrutiny

Nature (London), 2017-08, Vol.548 (7667), p.287-288

Bova, G Steven

2017

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(122)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(26)
The Journal Of Urology
(17)
The Prostate
(14)
Nature Genetics
(7)
Nature
(5)
Cancer Epidemiology, Biomarkers & Prevention
(4)
Clinical Cancer Research
(3)
Genes Chromosomes & Cancer
(3)
Science
(3)
The American Journal Of Pathology
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The evolutionary history of lethal metastatic prostate cancer

Hedgehog signalling in prostate regeneration, neoplasia and metastasis

Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth

Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression

Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements

Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer

Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases

DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity

Proteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumors

The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource

Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases

Fanconi anemia pathway regulation by FANCI in prostate cancer

DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity

Roles for the stem cell-associated intermediate filament nestin in prostate cancer migration and metastasis

Hypermethylation of CpG islands in primary and metastatic human prostate cancer

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer

Detection and Verification of Glycosylation Patterns of Glycoproteins from Clinical Specimens Using Lectin Microarrays and Lectin-Based Immunosorbent Assays

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine

Somatic Alterations Contributing to Metastasis of a Castration-Resistant Prostate Cancer

Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells

Cancer genomics: Human metastases under scrutiny

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

Suchergebnisse filtern